Your browser doesn't support javascript.
loading
Evorpacept alone and in combination with pembrolizumab or trastuzumab in patients with advanced solid tumours (ASPEN-01): a first-in-human, open-label, multicentre, phase 1 dose-escalation and dose-expansion study.
Lakhani, Nehal J; Chow, Laura Q M; Gainor, Justin F; LoRusso, Patricia; Lee, Keun-Wook; Chung, Hyun Cheol; Lee, Jeeyun; Bang, Yung-Jue; Hodi, Frank Stephen; Kim, Won Seog; Santana-Davila, Rafael; Fanning, Philip; Squifflet, Pierre; Jin, Feng; Kuo, Tracy C; Wan, Hong I; Pons, Jaume; Randolph, Sophia S; Messersmith, Wells A.
Afiliação
  • Lakhani NJ; START Midwest, Grand Rapids, MI, USA.
  • Chow LQM; Department of Oncology, University of Washington, Seattle, WA, USA; Department of Oncology University of Texas, Austin, TX, USA.
  • Gainor JF; Massachusetts General Hospital Cancer Center, Boston, MA, USA.
  • LoRusso P; Yale Cancer Center, New Haven, CT, USA.
  • Lee KW; Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
  • Chung HC; Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Korea.
  • Lee J; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
  • Bang YJ; Seoul National University College of Medicine, Seoul, Korea.
  • Hodi FS; Dana Farber Cancer Center, Boston, MA, USA.
  • Kim WS; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Korea.
  • Santana-Davila R; Department of Oncology, University of Washington, Seattle, WA, USA.
  • Fanning P; ALX Oncology, South San Francisco, CA, USA.
  • Squifflet P; International Drug Development Institute, Brussels, Belgium.
  • Jin F; ALX Oncology, South San Francisco, CA, USA.
  • Kuo TC; ALX Oncology, South San Francisco, CA, USA.
  • Wan HI; ALX Oncology, South San Francisco, CA, USA.
  • Pons J; ALX Oncology, South San Francisco, CA, USA.
  • Randolph SS; ALX Oncology, South San Francisco, CA, USA. Electronic address: srandolph@alxoncology.com.
  • Messersmith WA; University of Colorado Cancer Center, Aurora, CO, USA.
Lancet Oncol ; 22(12): 1740-1751, 2021 12.
Article em En | MEDLINE | ID: mdl-34793719
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article